Although APOC2 has been implied as a biomarker in pancreatic and cervical cancer [114], an overexpression of APOC3 has been described in ovarian cancer and in the recurrent disease of small-cell lung cancer patients [115]. This evidence concerns the gene APOC3 and small cell lung carcinoma.